ProQR Therapeutics
(NASDAQ) PRQR
ProQR Therapeutics Financials at a Glance
Market Cap
$199.13M
Revenue (TTM)
€13.44M
Net Income (TTM)
-€45.62M
EPS (TTM)
-$0.50
P/E Ratio
-3.76
Dividend
$0.00
Beta (Volatility)
1.38 (Average)
Dividend
$0.00
Beta (Volatility)
1.38 (Average)
Price
$1.86
Volume
1,378,074.332
Open
$1.67
Price
$1.86
Volume
1,378,074.332
Open
$1.67
Previous Close
$1.89
Daily Range
$1.67 - $1.97
52-Week Range
$1.33 - $3.10
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.38 (Average)
Price
$1.86
Volume
1,378,074.332
Open
$1.67
Previous Close
$1.89
Daily Range
$1.67 - $1.97
52-Week Range
$1.33 - $3.10
Estimated Earnings Date
Aug 6, 2026
PRQR News
PRQR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ProQR Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
186.6
CEO
Daniel Anton de Boer
Website
www.proqr-tx.comHeadquarters
Leiden, 2333 Ck, NL
PRQR Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-82%
Return on Capital
-73%
Return on Assets
-46%
Earnings Yield
-26.60%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$199.13M
Shares Outstanding
105.36M
Volume
1.38M
Avg. Volume
643.60K
Financials (TTM)
Gross Profit
€12.68M
Operating Income
-€42.15M
EBITDA
-€37.04M
Operating Cash Flow
-€50.71M
Capital Expenditure
-€979.75K
Free Cash Flow
-€51.69M
Cash & ST Invst.
€92.37M
Total Debt
€13.99M
ProQR Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€2.07M
-54.3%
Gross Profit
€1.36M
-69.9%
Gross Margin
65.86%
N/A
Market Cap
$199.13M
N/A
Market Cap/Employee
$1.20M
N/A
Employees
166
N/A
Net Income
-€13.60M
-35.0%
EBITDA
-€12.90M
-37.2%
Quarterly Fundamentals
Total Cash
€81.17M
-43.2%
Total Debt
€13.70M
-16.0%
Accounts Receivable
€2.72M
-8.7%
Inventory
€0.00
N/A
Long Term Debt
€9.08M
-21.7%
Short Term Debt
€4.62M
-1.9%
Return on Assets
-46.02%
N/A
Return on Invested Capital
-72.52%
N/A
Free Cash Flow
-€11.49M
+28.3%
Operating Cash Flow
-€11.33M
+28.3%